Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03086343 |
|---|---|
| Brief Title: | A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs ( SELECT-CHOICE ) (SELECT-CHOICE) |
| First Submitted : | March 20, 2017 |
| First Submitted that Met QC Criteria : | March 20, 2017 |
| First Posted : | March 22, 2017 |
| Last Update Submitted that Met QC Criteria : | March 20, 2019 |
| Last Update Posted : | March 22, 2019 |